➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Express Scripts

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

FENOLDOPAM MESYLATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

DrugPatentWatch® Litigation and Generic Entry Outlook for Fenoldopam Mesylate

A generic version of FENOLDOPAM MESYLATE was approved as fenoldopam mesylate by WEST-WARD PHARMS INT on October 12th, 2004.

  Try it Free

Summary for FENOLDOPAM MESYLATE
Drug patent expirations by year for FENOLDOPAM MESYLATE
Recent Clinical Trials for FENOLDOPAM MESYLATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Roma La SapienzaPhase 4
Southeast Renal Research InstitutePhase 4
Dialysis Clinic, Inc.Phase 2/Phase 3

See all FENOLDOPAM MESYLATE clinical trials

Medical Subject Heading (MeSH) Categories for FENOLDOPAM MESYLATE

US Patents and Regulatory Information for FENOLDOPAM MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 076656-001 Dec 1, 2003 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
West-ward Pharms Int FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 076582-001 Oct 12, 2004 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sandoz Inc FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 077155-001 Feb 15, 2005 AP RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva Parenteral FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 077826-001 Mar 7, 2007 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Boehringer Ingelheim
Mallinckrodt
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.